Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients <it>in vivo</it>: results from a randomized clinical trial of IL-2 with or without histamine (MP 104)
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-07-01
|
| Series: | Cancer Cell International |